Identification and characterization of glyceraldehyde 3-phosphate dehydrogenase from Fasciola gigantica
- 31 Downloads
Fasciola gigantica is an important food-borne trematode responsible for the hepatobiliary disease, commonly known as fascioliasis. In F. gigantica, the glyceraldehyde 3-phosphate dehydrogenase (FgGAPDH) is a key enzyme of the glycolytic pathway and catalyzes the reversible oxidative phosphorylation of d-glyceraldehyde-3-phosphate (G-3-P) to 1,3-bisphosphoglycerate (1,3-BPG), with the simultaneous reduction of NAD+ to NADH. In the present study, we analyzed the sequence of FgGAPDH and investigated its structural, binding, and catalytic properties. Sequence alignment of FgGAPDH showed 100% identity with the sister fluke Fasciola hepatica GAPDH. The gapdh gene was cloned and expressed in Escherichia coli, and the recombinant protein was purified. The purified FgGAPDH exists as a homo-tetramer, composed of a ~ 37-kDa subunit under non-dissociating conditions at 300 mM salt concentration indicating that higher salt stabilizes the tetrameric state. The binding of the cofactor NAD+ caused a conformational rearrangement in the enzyme structure, leading to the stabilization of the enzyme. A homology model of FgGAPDH was constructed, the cofactor (NAD+) and substrate (G-3-P) were docked, and the binding sites were identified in a single chain. The inter-subunit cleft of GAPDH that has been exploited for structure-based drug design in certain protozoan parasites is closed in the case of FgGAPDH, similar to the human GAPDH. Thus, the conformation of FgGAPDH in this region is similar to the human enzyme. Therefore, GAPDH may not be a suitable target for drug discovery against fascioliasis. Still, the analysis of the structural and functional attributes of GAPDH will be significant in understanding the various roles of this enzyme in the parasite as well as provide new insights into the biochemistry of flukes.
KeywordsFasciola gigantica Liver fluke Glyceraldehyde 3-phosphate dehydrogenase Activity Modeling Docking Quenching
Glyceraldehyde 3-phosphate dehydrogenase
F. gigantica glyceraldehyde 3-phosphate dehydrogenase
Size exclusion chromatography
PBC and RS carried out all the experiments. PBC, RS, and TT analyzed the data, conceived the study, and participated in its design and coordination and drafted the manuscript. All authors read and approved the final manuscript.
Compliance with ethical standards
The authors declare that there are no competing interests.
- Bero J, Beaufay C, Hannaert V, Herent MF, Michels PA, Quetin-Leclercq J (2013) Antitrypanosomal compounds from the essential oil and extracts of Keetia leucantha leaves with inhibitor activity on Trypanosoma brucei glyceraldehyde-3-phosphate dehydrogenase. Phytomedicine 20(3–4):270–274. https://doi.org/10.1016/j.phymed.2012.10.010 CrossRefGoogle Scholar
- Biu AA, Ahmed MI, Mshelia SS (2006) Economic assessment of losses due to parasitic diseases common at the Maiduguri abattoir, Nigeria. vol 7, p 143–145Google Scholar
- Carlile GW, Chalmers-Redman RM, Tatton NA, Pong A, Borden KE, Tatton WG (2000) Reduced apoptosis after nerve growth factor and serum withdrawal: conversion of tetrameric glyceraldehyde-3-phosphate dehydrogenase to a dimer. Mol Pharmacol 57(1):2–12Google Scholar
- Ganapathy-Kanniappan S et al (2009) Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is pyruvylated during 3-bromopyruvate mediated cancer cell death. Anticancer Res 29(12):4909–4918Google Scholar
- Ganapathy-Kanniappan S, Kunjithapatham R, Geschwind JF (2013) Anticancer efficacy of the metabolic blocker 3-bromopyruvate: specific molecular targeting. Anticancer Res 33(1):13–20Google Scholar
- Mas-Coma S, Funatsu IR, Bargues MD (2001) Fasciola hepatica and lymnaeid snails occurring at very high altitude in South America. Parasitology 123(Suppl):S115–S127Google Scholar
- Nelson D, Goldstein JM, Boatright K, Harty DWS, Cook SL, Hickman PJ, Potempa J, Travis J, Mayo JA (2001) pH-regulated secretion of a glyceraldehyde-3-phosphate dehydrogenase from Streptococcus gordonii FSS2: purification, characterization, and cloning of the gene encoding this enzyme. J Dent Res 80(1):371–377CrossRefGoogle Scholar
- Pathak RK, Baunthiyal M, Shukla R, Pandey D, Taj G, Kumar A (2017) In silico identification of mimicking molecules as defense inducers triggering jasmonic acid mediated immunity against Alternaria blight disease in Brassica species. Front Plant Sci 8:609. https://doi.org/10.3389/fpls.2017.00609 CrossRefGoogle Scholar
- Shukla H, Shukla R, Sonkar A, Tripathi T (2017b) Alterations in conformational topology and interaction dynamics caused by L418A mutation leads to activity loss of Mycobacterium tuberculosis isocitrate lyase. Biochem Biophys Res Commun 490:276–282. https://doi.org/10.1016/j.bbrc.2017.06.036 CrossRefGoogle Scholar
- Soares FA, Sesti-Costa R, da Silva JS, de Souza MCBV, Ferreira VF, da C. Santos F, Monteiro PAU, Leitão A, Montanari CA (2013) Molecular design, synthesis and biological evaluation of 1,4-dihydro-4-oxoquinoline ribonucleosides as TcGAPDH inhibitors with trypanocidal activity. Bioorg Med Chem Lett 23(16):4597–4601. https://doi.org/10.1016/j.bmcl.2013.06.029 CrossRefGoogle Scholar
- WHO (2015) WHO estimates of the global burden of foodborne diseases: foodborne disease burden epidemiology reference group 2007–2015. World Health OrganizationGoogle Scholar